NRX PHARMACEUTICALS INC's ticker is NRXPW and the CUSIP is 629444118. A total of 5 filers reported holding NRX PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1 | -75.0% | 15 | 0.0% | 0.00% | – |
| Q2 2023 | $4 | – | 15 | 0.0% | 0.00% | – |
| Q1 2023 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q4 2022 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | – | 15 | 0.0% | 0.00% | – |
| Q2 2021 | $0 | – | 15 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yakira Capital Management, Inc. | 17,129 | $1,372 | 0.00% |
| UBS Group AG | 7,812 | $625 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 600 | $48 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| WOLVERINE ASSET MANAGEMENT LLC | 12,426 | $995 | 0.00% |
| Tower Research Capital LLC (TRC) | 15 | $1 | 0.00% |